Clinical Trial Update: Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion [NA]

View source ↗

Summary

Clinical trial update reporting on the effect of canagliflozin in Type 1 diabetes after interruption of continuous subcutaneous insulin infusion; study status c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Yale University | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2018-11-29